"Peptide Fragments" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques.
| Descriptor ID |
D010446
|
| MeSH Number(s) |
D12.644.541
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Peptide Fragments".
Below are MeSH descriptors whose meaning is more specific than "Peptide Fragments".
This graph shows the total number of publications written about "Peptide Fragments" by people in this website by year, and whether "Peptide Fragments" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 7 | 8 |
| 1995 | 1 | 5 | 6 |
| 1996 | 5 | 5 | 10 |
| 1997 | 3 | 8 | 11 |
| 1998 | 5 | 7 | 12 |
| 1999 | 5 | 10 | 15 |
| 2000 | 2 | 10 | 12 |
| 2001 | 5 | 8 | 13 |
| 2002 | 6 | 3 | 9 |
| 2003 | 8 | 12 | 20 |
| 2004 | 8 | 10 | 18 |
| 2005 | 9 | 11 | 20 |
| 2006 | 4 | 10 | 14 |
| 2007 | 3 | 5 | 8 |
| 2008 | 8 | 8 | 16 |
| 2009 | 9 | 5 | 14 |
| 2010 | 5 | 12 | 17 |
| 2011 | 6 | 1 | 7 |
| 2012 | 1 | 8 | 9 |
| 2013 | 6 | 9 | 15 |
| 2014 | 3 | 7 | 10 |
| 2015 | 10 | 4 | 14 |
| 2016 | 5 | 5 | 10 |
| 2017 | 5 | 3 | 8 |
| 2018 | 4 | 5 | 9 |
| 2019 | 3 | 4 | 7 |
| 2020 | 8 | 6 | 14 |
| 2021 | 2 | 4 | 6 |
| 2022 | 0 | 3 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Peptide Fragments" by people in Profiles.
-
Baroreflex activation therapy with the Barostim? device in patients with heart failure with reduced ejection fraction: a patient level meta-analysis of randomized controlled trials. Eur J Heart Fail. 2022 09; 24(9):1665-1673.
-
Association of soluble Flt-1 with heart failure and cardiac morphology: The MESA angiogenesis study. J Heart Lung Transplant. 2022 05; 41(5):619-625.
-
Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2022 03; 24(3):497-509.
-
Evaluation of Therapeutic Collagen-Based Biomaterials in the Infarcted Mouse Heart by Extracellular Matrix Targeted MALDI Imaging Mass Spectrometry. J Am Soc Mass Spectrom. 2021 Dec 01; 32(12):2746-2754.
-
Development and external validation of prognostic models to predict sudden and pump-failure death in patients with HFrEF from PARADIGM-HF and ATMOSPHERE. Clin Res Cardiol. 2021 Aug; 110(8):1334-1349.
-
Response by Sex in Patient-Centered Outcomes With Baroreflex Activation Therapy in Systolic Heart?Failure. JACC Heart Fail. 2021 06; 9(6):430-438.
-
Advancing Rational Control of Peptide-Surface Complexes. J Phys Chem B. 2021 03 18; 125(10):2644-2657.
-
Carvedilol Does Not Improve Exercise Performance in Fontan Patients: Results of a Crossover Trial. Pediatr Cardiol. 2021 Apr; 42(4):934-941.
-
Clinical Characteristics and Outcomes of Patients With Heart Failure With Reduced Ejection Fraction and Chronic Obstructive Pulmonary Disease: Insights From PARADIGM-HF. J Am Heart Assoc. 2021 02 16; 10(4):e019238.
-
Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2. Bioconjug Chem. 2021 01 20; 32(1):215-223.